Name and Position
Dr Farasat KazmiConsultants
Oncology
Contact Details
Main Telephone Number:01603 286748Profile

Department page: Oncology
Specialties: Clinical Oncology: Lung, Gynaecological and Non Melanoma Skin malignancies
Sub-Speciality: Lung Stereotactic Ablative Radiotherapy, Precision Oncology and Early & Late Phase Clinical Trials
Areas of Expertise
- Lung SABR and advanced radiotherapy techniques
- Systemic therapies with targeted therapies, immunotherapies and chemotherapy
- Targeted and precision oncology therapies
- Management of complex and advanced cancers
Secretary: Laura Fitt
Research & Academic Interests: Dr Kazmi has an established track record in clinical and translational oncology research, with over 40 peer-reviewed publications and an H-index of 8. His research focuses on targeted therapies, next-generation sequencing, and clinical trial methodology.
He has held key national and international research roles, including:
- Principal Investigator for a Cochrane systematic review on next-generation sequencing–guided targeted therapies
- Early Career Researcher with the Lancet Breast Cancer Commission
- Principal Investigator in multiple clinic trial
- Member of the Scientific Advisory Committee for the World Conference on Lung Cancer 2025
His work also includes involvement in early-phase drug development and investigator-led studies in advanced cancers, with a particular interest in improving patient-reported outcomes and trial design.
Current Membership of Professional, National and Regional Bodies:
- Fellow of the Royal College of Radiologists (FRCR)
- Member of the Royal College of Physicians (MRCP, UK)
- Member of the Royal College of Surgeons (MRCS, Edinburgh)
- Active contributor to national and international oncology research groups and collaborative trials
Universities and Degrees:
- FRCR (Clinical Oncology), 2024
- MRCP (UK), 2021
- MSc Nanomedicine and Healthcare, University of Oxford, 2018
- MRCS (Edinburgh), 2017
- MB BCh BAO LRCP, Royal College of Surgeons in Ireland, 2013
GMC Number: 7707258


